Adamas to Present at Upcoming June Conferences

Rhea-AI Summary

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) will participate in two key conferences in June 2021. Chief Financial Officer Christopher B. Prentiss will present at the William Blair 41st Annual Growth Stock Conference on June 3 at 11:00 am ET. CEO Neil F. McFarlane will engage in a fireside chat at the JMP Securities Life Sciences Conference on June 16 at 3:30 pm ET. Both events will be streamed live on Adamas' investor relations website and replays will be available for 30 days.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that the organization will be participating in two upcoming June conferences:

• Christopher B. Prentiss, Chief Financial Officer will present at the William Blair 41st Annual Growth Stock Conference on Thursday, June 3 2021 at 11:00 am Eastern Time.
• Neil F. McFarlane, Chief Executive Officer will participate in a fireside chat at the JMP Securities Life Sciences Conference on Wednesday, June 16 at 3:30 pm Eastern Time.

Both the presentation and the fireside chat will be broadcast live from the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. Replays of the events will be available for 30 days.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.

Source: Adamas Pharmaceuticals, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210527005789/en/

FAQ

When is the William Blair 41st Annual Growth Stock Conference for Adamas Pharmaceuticals?

Adamas Pharmaceuticals will present at the William Blair 41st Annual Growth Stock Conference on June 3, 2021, at 11:00 am Eastern Time.

Who will represent Adamas Pharmaceuticals at the JMP Securities Life Sciences Conference?

CEO Neil F. McFarlane will participate in a fireside chat at the JMP Securities Life Sciences Conference on June 16, 2021, at 3:30 pm Eastern Time.

Where can I watch the Adamas Pharmaceuticals conference presentations?

Both presentations will be broadcast live on Adamas' investor relations website, accessible at http://ir.adamaspharma.com/events-presentations.

Will the Adamas Pharmaceuticals conference presentations be available later?

Yes, replays of both the William Blair conference and the JMP Securities conference will be available for 30 days after the events.

What is the focus of Adamas Pharmaceuticals?

Adamas Pharmaceuticals focuses on developing innovative medicines to address neurological diseases and reduce their burden on patients and caregivers.